What are the major drivers for the global viral sepsis diagnostics market growth?

The primary factors propelling the market growth are the growing demand for viral infection diagnostics and the rising awareness of rapid sepsis detection solutions. Additionally, advancements in molecular diagnostic assays along with the expansion of point-of-care sepsis tests are expected to support the market growth.

Viral Sepsis Diagnostics Market

Global Viral Sepsis Diagnostics Market Size, Trends & Analysis - Forecasts to 2029 By Diagnostic Method (Molecular Diagnostics, Serological Testing, Point-of-Care Testing, and Others), By Virus Type (Influenza Virus, Respiratory Syncytial Virus (RSV), Herpes Simplex Virus (HSV), Human Immunodeficiency Virus (HIV), Hepatitis Viruses (HCV, HBV), Dengue Virus, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

15% off

Home > Market Analysis > Healthcare > Diagnostics > Viral Sepsis Diagnostics Market

Viral Sepsis Diagnostics Market - Market Overview

Global Viral Sepsis Diagnostics Market Size

The global viral sepsis diagnostics market is estimated to exhibit a CAGR of 9.4% from 2024 to 2029.

The primary factors propelling the market growth are the growing demand for viral infection diagnostics and the rising awareness of rapid sepsis detection solutions. The viral infection diagnostics surge is fueled by the need for advanced viral sepsis testing methods to identify and manage sepsis cases caused by viral pathogens accurately. Enhanced sepsis biomarker detection techniques are crucial for timely diagnosis, facilitating appropriate and swift treatment decisions. Innovative Viral sepsis screening tools are increasingly being developed and adopted, providing healthcare professionals with reliable means to detect sepsis early. Moreover, immunoassay-based sepsis tests are gaining traction due to their high specificity and sensitivity in identifying viral sepsis biomarkers. These advancements not only improve patient outcomes but also drive market growth as healthcare systems worldwide prioritize effective sepsis management. For instance, 12,150 instances of sepsis were reported in 2022 in Ireland, up 7.9% from 2021 (11,265), according to the National Sepsis Outcome Report 2022.

Advancements in molecular diagnostic assays and the expansion of point-of-care sepsis tests are expected to support the market growth. Integrating blood culture diagnostics at the point-of-care allows for quicker pathogen identification, thus expediting treatment. Moreover, the development of advanced sepsis diagnostic algorithms enhances the accuracy and efficiency of these tests, aiding in early and precise diagnosis. The identification of viral sepsis prognosis markers further refines the predictive capabilities of point-of-care diagnostics, enabling tailored treatment plans. Additionally, the incorporation of diagnostic imaging for sepsis at the point-of-care provides comprehensive insights into the patient's condition, supporting thorough and informed medical decisions.

The development of innovative sepsis diagnosis technologies and the rising incidence of septic shock diagnosis cases propel market growth. Advances in clinical microbiology testing are leading to more precise and rapid identification of pathogens, crucial for effective sepsis management. These innovations align with evolving sepsis diagnostic guidelines, ensuring healthcare practices stay current with the latest standards and recommendations for accurate diagnosis and treatment. Additionally, comprehensive sepsis diagnostic market analysis reveals a growing demand for advanced diagnostic tools that can quickly and accurately detect viral sepsis. The integration of cutting-edge technologies, such as molecular diagnostics and next-generation sepsis diagnostics, is transforming the landscape of sepsis diagnosis.

By providing quicker and more precise identification of sepsis-causing organisms, emerging sepsis diagnostic technologies, including next-generation sequencing (NGS) and polymerase chain reaction (PCR) tests, are creating opportunities in the market. Additionally, sepsis diagnostic technologies are incorporating machine learning and artificial intelligence to improve patient stratification, lessen false positives, and improve prediction and diagnostic accuracy.

However, viral sepsis diagnostic challenges such as the overlap of symptoms and the need for specific biomarkers and high cost of advanced diagnostic tools impede market growth.

global viral sepsis diagnostics market

Global Viral Sepsis Diagnostics Market: By Diagnostic Method

The molecular diagnostics segment is expected to hold the largest share of the market over the forecast period. Compared to conventional procedures, molecular diagnostic testing can yield findings considerably more quickly. Proper antiviral medication's timely commencement is crucial in controlling sepsis and lowering death rates, and it is made possible by the prompt identification of the causal virus.

The point-of-care testing segment is expected to be the fastest-growing segment in the market from 2024 to 2029. Point-of-care testing is intended to be conveniently conducted in non-laboratory contexts, such as emergency rooms, critical care units, or outpatient clinics. Due to its ease of use and accessibility, patients can be tested, and decisions can be made quickly, which speeds up the process of starting the right therapy and enhances patient outcomes.

Global Viral Sepsis Diagnostics Market: By Virus Type

The influenza virus segment is expected to hold the largest share of the market over the forecast period. Influenza viruses, especially influenza A and B, are among the most prevalent viral pathogens linked to sepsis and respiratory diseases. Seasonal influenza epidemics happen every year and heavily impact global healthcare systems. The increasing incidence of influenza partly causes the increased need for diagnostic testing, particularly for this virus, driving market growth.

The dengue virus segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Dengue virus infections can present a wide spectrum of clinical manifestations, ranging from mild febrile illness to severe and potentially life-threatening disease. Severe dengue cases may involve vascular leakage, plasma leakage, and systemic inflammation, which can progress rapidly to severe sepsis and septic shock.

asia pacific viral sepsis diagnostics market

Global Viral Sepsis Diagnostics Market: By Region

North America is expected to be the largest region in the global market. Viral infections such as influenza, respiratory syncytial virus (RSV), herpes simplex virus (HSV), and others are common in North America and can cause sepsis. The frequency of these illnesses drives the need for effective viral sepsis diagnostics.

Asia Pacific is anticipated to witness rapid growth during the forecast period. The Asia Pacific region's economic growth has raised investments in healthcare technologies and spending on healthcare services. The need for cutting-edge diagnostic techniques, such as viral sepsis diagnostics, is rising as the region's healthcare institutions modernize and put a greater emphasis on improving patient outcomes.

Global Viral Sepsis Diagnostics Market Share and Competitor Analysis

Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Cepheid (a subsidiary of Danaher Corporation), F. Hoffmann-La Roche Ltd, Hologic, Inc., Luminex Corporation, Quidel Corporation, Thermo Fisher Scientific Inc., and Becton, Dickinson and Company, among others, are some of the key players in the global viral sepsis diagnostics market.

Please note: This is not an exhaustive list of companies profiled in the report.

Global Viral Sepsis Diagnostics Market: Recent Developments

In February 2023, Immunexpress launched the SeptiCyte Rapid test in the United States. This test allows for hourly sepsis diagnosis in patients. The point-of-care test can improve outcomes and enable timely intervention by assisting doctors in identifying patients early.

In January 2023, the new IntelliSep sepsis diagnostic test was launched by Cytovale. The enhanced test is intended for sepsis patients admitted to emergency rooms.

Viral Sepsis Diagnostics Market - Methodology

Data Procurement

This stage involves collecting market data using secondary research, purchased databases, and industry databases.

Data Analysis

This stage involves analyzing and reconciling information from third party perspectives, primary interviews, surveys, and questionnaire-based research.

Market Formulation

This stage involves positioning data points to draw conclusions using market derivation, value chain analysis, penetration modeling, product sizing, forecasting, usage rates, and expert insights.

Validation & Publishing

This stage involves to meticulously validate and re-validate data through bottom-up approach, top-down approach, regression analysis, variable analysis, trend analysis, growth estimation, and historical market trends for accurate final calculations.

The iterative process between phases 1 and 2 is bidirectional, crucial for data filtration. It involves database management, information procurement, analysis, user size analysis, technological advancements, and market impact.The validation and market formulation stages exhibit reversible characteristics, operating concurrently to guarantee data precision and procedural adaptability.

Throughout the tenure, we engage in market sizing and point identification processes. Phases 1 & 2 lead to 3 & 4. This iterative process continues until each data point is rigorously validated and ready for release

Viral Sepsis Diagnostics Market - Table of Contents

1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1 Strategic Opportunity & Attractiveness Analysis

1.1.1 Hot Revenue Pockets

1.1.2 Market Attractiveness Score

1.1.3 Revenue Impacting Opportunity

1.1.4 High Growing Region/Country

1.1.5 Competitor Analysis

1.1.6 Consumer Analysis

1.2 Global Market Estimates' View

1.3 Strategic Insights across Business Functions

1.3.1 For Chief Executive Officers

1.3.2 For Chief Marketing Officers

1.3.3 For Chief Strategy Officers

1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2 TECHNOLOGICAL TRENDS

2.1 Technological Adoption Rate

2.2 Current Trend Impact Analysis

2.3 Future Trend Impact Analysis

3 GLOBAL MARKET OUTLOOK

3.1 Market Pyramid Analysis

3.1.1 Introduction

3.1.2 Adjacent Market Opportunities

3.1.3 Ancillary Market Opportunities

3.2 Demand Side Analysis

3.2.1 Market Drivers: Impact Analysis

3.2.2 Market Restraints: Impact Analysis

3.2.3 Market Opportunities: Impact Analysis

3.2.4 Market Challenges: Impact Analysis

3.3 Supply Side Analysis

3.3.1 Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3 Value Chain Analysis

3.3.4 Trend Analysis

3.3.5 Gap Analysis

3.3.6 Cost Analysis

4 GLOBAL VIRAL SEPSIS DIAGNOSTICS MARKET, BY Diagnostic Method

4.1 Introduction

4.2 Viral Sepsis Diagnostics Market: Diagnostic Method Scope Key Takeaways

4.3 Revenue Growth Analysis, 2023 & 2029

4.4 Molecular Diagnostics

4.4.1 Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

4.5 Serological Testing

4.5.1 Serological Testing Market Estimates and Forecast, 2021-2029 (USD Million)

4.6 Point-of-Care Testing

4.6.1 Point-of-Care Testing Market Estimates and Forecast, 2021-2029 (USD Million)

4.7 Others

4.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)

5 GLOBAL VIRAL SEPSIS DIAGNOSTICS MARKET, BY VIRUS TYPE

5.1 Introduction

5.2 Viral Sepsis Diagnostics Market: Virus Type Scope Key Takeaways

5.3 Revenue Growth Analysis, 2023 & 2029

5.4 Influenza Virus

5.4.1 Influenza Virus Market Estimates and Forecast, 2021-2029 (USD Million)

5.5 Respiratory Syncytial Virus (RSV)

5.5.1 Respiratory Syncytial Virus (RSV) Market Estimates and Forecast, 2021-2029 (USD Million)

5.6 Herpes Simplex Virus (HSV)

5.6.1 Herpes Simplex Virus (HSV) Market Estimates and Forecast, 2021-2029 (USD Million)

5.7 Human Immunodeficiency Virus (HIV)

5.7.1 Human Immunodeficiency Virus (HIV) Market Estimates and Forecast, 2021-2029 (USD Million)

5.8 Hepatitis Viruses (HCV, HBV)

5.8.1 Hepatitis Viruses (HCV, HBV) Market Estimates and Forecast, 2021-2029 (USD Million)

5.9 Dengue Virus

5.9.1 Dengue Virus Market Estimates and Forecast, 2021-2029 (USD Million)

5.10 Others

5.10.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)

6 GLOBAL VIRAL SEPSIS DIAGNOSTICS MARKET, BY REGION

6.1 Introduction

6.2 North America Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.2.1 By Diagnostic Method

6.2.2 By Virus Type

6.2.3 By Country

6.2.3.1 U.S. Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.2.3.1.1 By Diagnostic Method

6.2.3.1.2 By Virus Type

6.2.3.2 Canada Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.2.3.2.1 By Diagnostic Method

6.2.3.2.2 By Virus Type

6.2.3.3 Mexico Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.2.3.3.1 By Diagnostic Method

6.2.3.3.2 By Virus Type

6.3 Europe Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.1 By Diagnostic Method

6.3.2 By Virus Type

6.3.3 By Country

6.3.3.1 Germany Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.1.1 By Diagnostic Method

6.3.3.1.2 By Virus Type

6.3.3.2 U.K. Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.2.1 By Diagnostic Method

6.3.3.2.2 By Virus Type

6.3.3.3 France Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.3.1 By Diagnostic Method

6.3.3.3.2 By Virus Type

6.3.3.4 Italy Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.4.1 By Diagnostic Method

6.3.3.4.2 By Virus Type

6.3.3.5 Spain Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.5.1 By Diagnostic Method

6.3.3.5.2 By Virus Type

6.3.3.6 Netherlands Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.6.1 By Diagnostic Method

6.3.3.6.2 By Virus Type

6.3.3.7 Rest of Europe Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.3.3.6.1 By Diagnostic Method

6.3.3.6.2 By Virus Type

6.4 Asia Pacific Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.1 By Diagnostic Method

6.4.2 By Virus Type

6.4.3 By Country

6.4.3.1 China Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.1.1 By Diagnostic Method

6.4.3.1.2 By Virus Type

6.4.3.2 Japan Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.2.1 By Diagnostic Method

6.4.3.2.2 By Virus Type

6.4.3.3 India Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.3.1 By Diagnostic Method

6.4.3.3.2 By Virus Type

6.4.3.4 South Korea Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.4.1 By Diagnostic Method

6.4.3.4.2 By Virus Type

6.4.3.5 Singapore Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.5.1 By Diagnostic Method

6.4.3.5.2 By Virus Type

6.4.3.6 Malaysia Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.6.1 By Diagnostic Method

6.4.3.6.2 By Virus Type

6.4.3.7 Thailand Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.6.1 By Diagnostic Method

6.4.3.6.2 By Virus Type

6.4.3.8 Indonesia Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.7.1 By Diagnostic Method

6.4.3.7.2 By Virus Type

6.4.3.9 Vietnam Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.8.1 By Diagnostic Method

6.4.3.8.2 By Virus Type

6.4.3.10 Taiwan Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.10.1 By Diagnostic Method

6.4.3.10.2 By Virus Type

6.4.3.11 Rest of Asia Pacific Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.4.3.11.1 By Diagnostic Method

6.4.3.11.2 By Virus Type

6.5 Middle East and Africa Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.5.1 By Diagnostic Method

6.5.2 By Virus Type

6.5.3 By Country

6.5.3.1 Saudi Arabia Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.5.3.1.1 By Diagnostic Method

6.5.3.1.2 By Virus Type

6.5.3.2 U.A.E. Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.5.3.2.1 By Diagnostic Method

6.5.3.2.2 By Virus Type

6.5.3.3 Israel Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.5.3.3.1 By Diagnostic Method

6.5.3.3.2 By Virus Type

6.5.3.4 South Africa Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.5.3.4.1 By Diagnostic Method

6.5.3.4.2 By Virus Type

6.5.3.5 Rest of Middle East and Africa Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.5.3.5.1 By Diagnostic Method

6.5.3.5.2 By Virus Type

6.6 Central and South America Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.6.1 By Diagnostic Method

6.6.2 By Virus Type

6.6.3 By Country

6.6.3.1 Brazil Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.6.3.1.1 By Diagnostic Method

6.6.3.1.2 By Virus Type

6.6.3.2 Argentina Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.6.3.2.1 By Diagnostic Method

6.6.3.2.2 By Virus Type

6.6.3.3 Chile Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.6.3.3.1 By Diagnostic Method

6.6.3.3.2 By Virus Type

6.6.3.3 Rest of Central and South America Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)

6.6.3.3.1 By Diagnostic Method

6.6.3.3.2 By Virus Type

7 COMPETITIVE LANDCAPE

7.1 Company Market Share Analysis

7.2 Four Quadrant Positioning Matrix

7.2.1 Market Leaders

7.2.2 Market Visionaries

7.2.3 Market Challengers

7.2.4 Niche Market Players

7.3 Vendor Landscape

7.3.1 North America

7.3.2 Europe

7.3.3 Asia Pacific

7.3.4 Rest of the World

7.4 Company Profiles

7.4.1 Abbott Laboratories

7.4.1.1 Business Description & Financial Analysis

7.4.1.2 SWOT Analysis

7.4.1.3 Products & Services Offered

7.4.1.4 Strategic Alliances between Business Partners

7.4.2 Bio-Rad Laboratories, Inc.

7.4.2.1 Business Description & Financial Analysis

7.4.2.2 SWOT Analysis

7.4.2.3 Products & Services Offered

7.4.2.4 Strategic Alliances between Business Partners

7.4.3 BioMérieux SA

7.4.3.1 Business Description & Financial Analysis

7.4.3.2 SWOT Analysis

7.4.3.3 Products & Services Offered

7.4.3.4 Strategic Alliances between Business Partners

7.4.4 Cepheid (a subsidiary of Danaher Corporation)

7.4.4.1 Business Description & Financial Analysis

7.4.4.2 SWOT Analysis

7.4.4.3 Products & Services Offered

7.4.4.4 Strategic Alliances between Business Partners

7.4.5 F. Hoffmann-La Roche Ltd

7.4.5.1 Business Description & Financial Analysis

7.4.5.2 SWOT Analysis

7.4.5.3 Products & Services Offered

7.4.5.4 Strategic Alliances between Business Partners

7.4.6 HOLOGIC, INC.

7.4.6.1 Business Description & Financial Analysis

7.4.6.2 SWOT Analysis

7.4.6.3 Products & Services Offered

7.4.6.4 Strategic Alliances between Business Partners

7.4.7 Luminex Corporation

7.4.7.1 Business Description & Financial Analysis

7.4.7.2 SWOT Analysis

7.4.7.3 Products & Services Offered

7.4.7.4 Strategic Alliances between Business Partners

7.4.8 Quidel Corporation

7.4.8.1 Business Description & Financial Analysis

7.4.8.2 SWOT Analysis

7.4.8.3 Products & Services Offered

7.4.8.4 Strategic Alliances between Business Partners

7.4.9 Thermo Fisher Scientific Inc.

7.4.9.1 Business Description & Financial Analysis

7.4.9.2 SWOT Analysis

7.4.9.3 Products & Services Offered

7.4.9.4 Strategic Alliances between Business Partners

7.4.10 Becton, Dickinson and Company

7.4.10.1 Business Description & Financial Analysis

7.4.10.2 SWOT Analysis

7.4.10.3 Products & Services Offered

7.4.10.4 Strategic Alliances between Business Partners

7.4.11 Other Companies

7.4.11.1 Business Description & Financial Analysis

7.4.11.2 SWOT Analysis

7.4.11.3 Products & Services Offered

7.4.11.4 Strategic Alliances between Business Partners

8 RESEARCH METHODOLOGY

8.1 Market Introduction

8.1.1 Market Definition

8.1.2 Market Scope & Segmentation

8.2 Information Procurement

8.2.1 Secondary Research

8.2.1.1 Purchased Databases

8.2.1.2 GMEs Internal Data Repository

8.2.1.3 Secondary Resources & Third Party Perspectives

8.2.1.4 Company Information Sources

8.2.2 Primary Research

8.2.2.1 Various Types of Respondents for Primary Interviews

8.2.2.2 Number of Interviews Conducted throughout the Research Process

8.2.2.3 Primary Stakeholders

8.2.2.4 Discussion Guide for Primary Participants

8.2.3 Expert Panels

8.2.3.1 Expert Panels Across 30+ Industry

8.2.4 Paid Local Experts

8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

8.3 Market Estimation

8.3.1 Top-Down Approach

8.3.1.1 Macro-Economic Indicators Considered

8.3.1.2 Micro-Economic Indicators Considered

8.3.2 Bottom Up Approach

8.3.2.1 Company Share Analysis Approach

8.3.2.2 Estimation of Potential Product Sales

8.4 Data Triangulation

8.4.1 Data Collection

8.4.2 Time Series, Cross Sectional & Panel Data Analysis

8.4.3 Cluster Analysis

8.5 Analysis and Output

8.5.1 Inhouse AI Based Real Time Analytics Tool

8.5.2 Output From Desk & Primary Research

8.6 Research Assumptions & Limitations

8.6.1 Research Assumptions

8.6.2 Research Limitations

LIST OF TABLES

1 Global Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

2 Molecular Diagnostics Market, By Region, 2021-2029 (USD Mllion)

3 Serological Testing Market, By Region, 2021-2029 (USD Mllion)

4 Point-of-Care Testing Market, By Region, 2021-2029 (USD Mllion)

5 Others Market, By Region, 2021-2029 (USD Mllion)

6 Global Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

7 Influenza Virus Market, By Region, 2021-2029 (USD Mllion)

8 Respiratory Syncytial Virus (RSV) Market, By Region, 2021-2029 (USD Mllion)

9 Herpes Simplex Virus (HSV) Market, By Region, 2021-2029 (USD Mllion)

10 Human Immunodeficiency Virus (HIV) Market, By Region, 2021-2029 (USD Mllion)

11 Hepatitis Viruses (HCV, HBV) Market, By Region, 2021-2029 (USD Mllion)

12 Dengue Virus Market, By Region, 2021-2029 (USD Mllion)

13 Others Market, By Region, 2021-2029 (USD Mllion)

14 Regional Analysis, 2021-2029 (USD Mllion)

15 North America Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

16 North America Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

17 North America Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)

18 U.S. Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

19 U.S. Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

20 Canada Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

21 Canada Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

22 Mexico Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

23 Mexico Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

24 Europe Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

25 Europe Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

26 EUROPE Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)

27 Germany Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

28 Germany Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

29 U.K. Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

30 U.K. Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

31 France Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

32 France Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

33 Italy Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

34 Italy Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

35 Spain Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

36 Spain Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

37 Netherlands Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

38 Netherlands Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

39 Rest Of Europe Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

40 Rest Of Europe Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

41 Asia Pacific Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

42 Asia Pacific Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

43 ASIA PACIFIC Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)

44 China Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

45 China Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

46 Japan Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

47 Japan Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

48 India Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

49 India Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

50 South Korea Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

51 South Korea Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

52 Singapore Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

53 Singapore Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

54 Thailand Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

55 Thailand Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

56 Malaysia Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

57 Malaysia Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

58 Indonesia Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

59 Indonesia Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

60 Vietnam Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

61 Vietnam Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

62 Taiwan Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

63 Taiwan Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

64 Rest of APAC Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

65 Rest of APAC Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

66 Middle East and Africa Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

67 Middle East and Africa Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

68 MIDDLE EAST & AFRICA Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)

69 Saudi Arabia Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

70 Saudi Arabia Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

71 UAE Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

72 UAE Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

73 Israel Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

74 Israel Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

75 South Africa Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

76 South Africa Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

77 Rest Of Middle East and Africa Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

78 Rest Of Middle East and Africa Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

79 Central and South America Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

80 Central and South America Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

81 CENTRAL AND SOUTH AMERICA Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)

82 Brazil Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

83 Brazil Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

84 Chile Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

85 Chile Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

86 Argentina Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

87 Argentina Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)

88 Rest Of Central and South America Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)

89 Rest Of Central and South America Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mll

You Can Purchase Parts of This Report. Check Out Prices for Specific Sections

FAQ's

About this Report

Download Sample